Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?

by István Vályi-Nagy, Ferenc Uher, Éva Rákóczi, Zoltán Szekanecz
Published 2022-11-01

The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells

by Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
Published 2023-03-01

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Boo...

by Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy
Published 2022-03-01

Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers

by Zsolt Matula, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, István Vályi-Nagy
Published 2023-12-01

Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells

by Zsolt Matula, Gábor Mikala, Szilvia Lukácsi, János Matkó, Tamás Kovács, Éva Monostori, Ferenc Uher, István Vályi-Nagy
Published 2021-07-01

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals

by Mihály Sulyok, Tamás Ferenci, Mihály Makara, Gábor Horváth, János Szlávik, Zsófia Rupnik, Luca Kormos, Zsuzsanna Gerlei, Zita Sulyok, István Vályi-Nagy
Published 2017-01-01

<i>IGH::NSD2</i> Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma

by András Bors, András Kozma, Ágnes Tomán, Zoltán Őrfi, Nóra Kondor, Szabolcs Tasnády, István Vályi-Nagy, Péter Reményi, Gábor Mikala, Hajnalka Andrikovics
Published 2024-01-01

Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.

by Diána Brauswetter, Bianka Gurbi, Attila Varga, Edit Várkondi, Richárd Schwab, Gábor Bánhegyi, Orsolya Fábián, György Kéri, István Vályi-Nagy, István Peták
Published 2017-01-01

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

by Anett Balikó, Anett Balikó, Zsolt Szakács, Béla Kajtár, Zsombor Ritter, Attila Gyenesei, Nelli Farkas, László Kereskai, István Vályi-Nagy, Hussain Alizadeh, László Pajor
Published 2023-09-01

Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems

by József Murányi, Attila Varga, Pál Gyulavári, Kinga Pénzes, Csilla E. Németh, Miklós Csala, Lilla Pethő, Antal Csámpai, Gábor Halmos, István Peták, István Vályi-Nagy
Published 2019-11-01

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

by György Sinkovits, Blanka Mező, Blanka Mező, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, László Gopcsa, Péter Reményi, Beáta Szathmáry, Botond Lakatos, János Szlávik, Ilona Bobek, Zita Z. Prohászka, Zsolt Förhécz, Dorottya Csuka, Lisa Hurler, Erika Kajdácsi, László Cervenak, Petra Kiszel, Tamás Masszi, István Vályi-Nagy, István Vályi-Nagy, Zoltán Prohászka, Zoltán Prohászka
Published 2021-03-01

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency

by Vera Goda, Gergely Kriván, Andrea Kulcsár, Márton Gönczi, Szabolcs Tasnády, Zsolt Matula, Ginette Nagy, Gabriella Bekő, Máté Horváth, Ferenc Uher, Zoltán Szekanecz, István Vályi-Nagy
Published 2022-06-01

Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, <i>ALK</i>-Positive, <i>TP53</i>-Mutant NSCLC

by László Urbán, Róbert Dóczi, Barbara Vodicska, Dóra Kormos, László Tóth, István Takács, Edit Várkondi, Dóra Tihanyi, Dóra Lakatos, Anna Dirner, István Vályi-Nagy, István Peták
Published 2020-08-01

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study

by Bálint Gergely Szabó, Péter Reményi, Szabolcs Tasnády, Dorina Korózs, László Gopcsa, Marienn Réti, Andrea Várkonyi, János Sinkó, Botond Lakatos, János Szlávik, Gabriella Bekő, Ilona Bobek, István Vályi-Nagy
Published 2023-07-01

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

by Petra Kövy, Zoltán Őrfi, András Bors, András Kozma, László Gopcsa, János Dolgos, Nóra Lovas, József Harasztdombi, Viktor Lakatos, Ágnes Király, Gábor Mikala, István Vályi-Nagy, Péter Reményi, Hajnalka Andrikovics
Published 2021-01-01

Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulat...

by Bálint Gergely Szabó, Eszter Czél, Imola Nagy, Dorina Korózs, Borisz Petrik, Bence Marosi, Zsófia Gáspár, Martin Rajmon, Márk Di Giovanni, István Vályi-Nagy, János Sinkó, Botond Lakatos, Ilona Bobek
Published 2023-07-01

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

by Anita Marx, Magdolna Osváth, Bence Szikora, Orsolya Pipek, István Csabai, Ákos Nagy, Csaba Bödör, Zsolt Matula, Ginette Nagy, András Bors, Ferenc Uher, Gábor Mikala, István Vályi-Nagy, Imre Kacskovics
Published 2023-01-01

The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies

by Bianka Gurbi, Diána Brauswetter, Attila Varga, Pál Gyulavári, Kinga Pénzes, József Murányi, Veronika Zámbó, Ede Birtalan, Tibor Krenács, David Laurence Becker, Miklós Csala, István Vályi-Nagy, István Peták, Kornél Dános
Published 2019-11-01

Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant

by Lörinc Polivka, Istvan Valyi-Nagy, Zoltan Szekanecz, Krisztina Bogos, Hajnalka Vago, Anita Kamondi, Ferenc Fekete, Janos Szlavik, György Surjan, Orsolya Surjan, Peter Nagy, Zsuzsa Schaff, Zoltan Kiss, Cecilia Müller, Miklos Kasler, Veronika Müller
Published 2023-11-01

Secondary malignancies and survival of FCR‐treated patients with chronic lymphocytic leukemia in Central Europe

by Fruzsina Kósa, Tereza Nečasová, Martin Špaček, Krzysztof Giannopoulos, Iwona Hus, Tereza Jurková, Eva Koriťáková, Marika Chrápavá, Martina Nováčková, Ivana Katinová, Denisa Krejčí, Adam Jujka, Zoltán Mátrai, István Vályi‐Nagy, Tadeusz Robak, Michael Doubek
Published 2023-01-01